Mainak Banerjee

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Topics

Ulcerative Colitis

Glycemic Control

Tyrosine Kinase

Coronavirus Disease

Top Venues

Postgraduate medical journal

The Journal of clinical endocrinology and metabolism

European heart journal

Cardiovascular drugs and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mainak Banerjee, Rimesh Pal, Sanjay Kumar Bhadada
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgraduate medical journal 98 (e2) (2023)
Mainak Banerjee, Rimesh Pal, Indira Maisnam, Subhankar Chowdhury, Satinath Mukhopadhyay
Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: A meta-analysis and meta-regression of randomized controlled trials. Diabetes, obesity & metabolism (2023)
Mainak Banerjee, Indira Maisnam, Satinath Mukhopadhyay
Letter to Editor from Banerjee et al.: "Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure". The Journal of clinical endocrinology and metabolism (2023)
Mainak Banerjee, Indira Maisnam, Satinath Mukhopadhyay
Impact of Heart Failure History at Baseline on Cardiovascular Effects of GLP-1 Receptor Agonists in Type 2 Diabetes: a Meta-analysis. Cardiovascular drugs and therapy (2023)
Mainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay, Kirthana Nair
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of clinical endocrinology and metabolism (2023)
Mainak Banerjee, Indira Maisnam, Rimesh Pal, Satinath Mukhopadhyay
Mineralocorticoid receptor antagonists with sodium-glucose co-transporter-2 inhibitors in heart failure: a meta-analysis. European heart journal (2023)
Mainak Banerjee
Epicardial Fat Paradox and Differential Effects of GLP-1 Receptor Agonists Across Heart Failure Phenotypes. Circulation. Heart failure (2023)
Sukrita Bhattacharjee, Mainak Banerjee, Rimesh Pal
ABO blood groups and severe outcomes in COVID-19: A meta-analysis. Postgraduate medical journal 98 (e2) (2022)
Mainak Banerjee, Rimesh Pal, Sanjay Kumar Bhadada
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgraduate medical journal 98 (e2) (2022)
Mainak Banerjee, Rimesh Pal, Satinath Mukhopadhyay
Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis. Acta diabetologica 59 (6) (2022)
Mainak Banerjee, Sunetra Mondal
Letter to the Editor from Banerjee and Mondal: "Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline". The Journal of clinical endocrinology and metabolism 107 (10) (2022)
Rimesh Pal, Mainak Banerjee, Urmila Yadav, Sukrita Bhattacharjee
Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis. Postgraduate medical journal (2021)
Mainak Banerjee, Rimesh Pal, Sanjay Kumar Bhadada
Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India. Postgraduate medical journal (2021)
Sukrita Bhattacharjee, Mainak Banerjee, Rimesh Pal
ABO blood groups and severe outcomes in COVID-19: A meta-analysis. Postgraduate medical journal (2020)
Mainak Banerjee, Sumit Kumar Mondal, Indira Maisnam, Apurba Kumar Mukherjee
Jaundice and anaemia as presenting features of an incomplete autoimmune polyglandular syndrome type II. BMJ case reports 12 (4) (2019)